Increased p53 expression in the malignant transformation of barrett's esophagus is accompanied by an upward shift of the proliferative compartment

Pathology and Oncology Research

Volumn 15, Issue 2, 2009, Pages 183-192

  Hritz, Istvan ^a   Gyorffy, Hajnalka ^a   Molnar, Bela ^a   Lakatos, Gabor ^a   Sipos, Ferenc ^a   Pregun, Istvan ^a   Juhasz, Mark ^a   Pronai, Laszlo ^a   Schaff, Zsuzsa ^a   Tulassay, Zsolt ^a   Herszenyi, Laszlo ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Adenocarcinoma; Barrett's esophagus; Cell proliferation; Dysplasia; P53 expression; Reflux esophagitis

Indexed keywords

CYCLINE; PROTEIN P53; KI 67 ANTIGEN; TP53 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PROTEIN EXPRESSION; REFLUX ESOPHAGITIS; ADENOCARCINOMA; CANCER STAGING; CELL TRANSFORMATION; ENZYME IMMUNOASSAY; ESOPHAGUS TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS, PEPTIC; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 68949127219     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-008-9095-z     Document Type: Article

References (48)

1. C Bosetti F Levi J Ferlay, et al. 2008 Trends in oesophageal cancer incidence and mortality in Europe Int J Cancer 122 5 1118 1129 10.1002/ijc.23232 1:CAS:528:DC%2BD1cXhslGgsrk%3D 17990321 (Pubitemid 351214012)
2. X Wu VW Chen PA Andrews, et al. 2007 Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences Cancer Causes Control 18 6 585 593 10.1007/s10552-007-9000-1 17406989 (Pubitemid 46883675)
3. JF Fléjou 2005 Barrett's oesophagus: from metaplasia to dysplasia and cancer Gut 54 Suppl 1 i6 i12 10.1136/gut.2004.041525 15711008 (Pubitemid 40293003)
4. SJ Spechler RK Goyal 1986 Barrett's esophagus N Engl J Med 315 6 362 371 1:STN:280:DyaL283osVymsw%3D%3D 2874485
5. B Westhoff S Brotze A Weston, et al. 2005 The frequency of Barrett's esophagus in high-risk patients with chronic GERD Gastrointest Endosc 61 2 226 231 10.1016/S0016-5107(04)02589-1 15729230 (Pubitemid 40261070)
6. JA Jankowski RF Harrison I Perry, et al. 2000 Barrett's metaplasia Lancet 356 9247 2079 2085 10.1016/S0140-6736(00)03411-5 1:STN:280: DC%2BD3M%2Fos1KntQ%3D%3D 11145505 (Pubitemid 32009828)
7. NJ Shaheen 2005 Advances in Barrett's esophagus and esophageal adenocarcinoma Gastroenterology 128 6 1554 1566 10.1053/j.gastro.2005.03.032 15887151 (Pubitemid 40692552)
8. A Srivastava JL Hornick X Li, et al. 2007 Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus Am J Gastroenterol 102 3 483 493 10.1111/j.1572-0241.2007.01073.x 17338734 (Pubitemid 46328161)
9. B Schlansky AJ Dimarino Jr D Loren, et al. 2006 A survey of oesophageal cancer: pathology, stage and clinical presentation Aliment Pharmacol Ther 23 5 587 593 10.1111/j.1365-2036.2006.02782.x 1:STN:280:DC%2BD28%2FpsVWmtw%3D%3D 16480397
10. M Skacel RE Petras TL Gramlich, et al. 2000 The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression Am J Gastroenterol 95 12 3383 3387 10.1111/j.1572-0241.2000.03348.x 1:STN:280:DC%2BD3M%2FpvFSgtQ%3D%3D 11151865
11. DT McManus A Olaru SJ Meltzer 2004 Biomarkers of esophageal adenocarcinoma and Barrett's esophagus Cancer Res 64 5 1561 1569 10.1158/0008-5472.CAN-03-2438 1:CAS:528:DC%2BD2cXhslektLs%3D 14996709 (Pubitemid 38428671)
12. M Younes A Ertan LV Lechago, et al. 1997 p53 protein accumulation is a specific marker of malignant potential in Barrett's metaplasia Dig Dis Sci 42 4 697 701 10.1023/A:1018828207371 1:CAS:528:DyaK2sXjtFOitrk%3D 9125634
13. MK Hong WB Laskin BE Herman, et al. 1995 Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus Cancer 75 2 423 429 10.1002/1097-0142(19950115)75:2<423::AID- CNCR2820750202>3.0.CO;2-5 1:STN:280:DyaK2M7ht1ahug%3D%3D 7812911
14. G Prelich CK Tan M Kostura, et al. 1987 Functional identity of proliferating cell nuclear antigen and a DNA polymerase auxiliary protein Nature 326 6112 517 520 10.1038/326517a0 1:CAS:528:DyaL2sXhvFWntrw%3D 2882424 (Pubitemid 17055499)
15. BJ Reid CA Sanchez PL Blount, et al. 1993 Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression Gastroenterology 105 1 119 129 1:STN:280:DyaK3s3pt1yjsA%3D%3D 8514029
16. WS el-Deiry JW Harper PM O'Connor, et al. 1994 WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis Cancer Res 54 5 1169 1174 1:CAS:528:DyaK2cXivFCkuro%3D 8118801
17. S Ramel BJ Reid CA Sanchez, et al. 1992 Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry Gastroenterology 102 4 Pt 1 1220 1228 1:STN:280:DyaK383gtFGmuw%3D%3D 1551529
18. DY Wang YY Xiang M Tanaka, et al. 1994 High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis Cancer 74 12 3089 3096 10.1002/1097-0142(19941215)74:12<3089::AID-CNCR2820741205>3.0.CO;2-N 1:STN:280:DyaK2M%2FntlWksw%3D%3D 7982172 (Pubitemid 24375063)
19. N Slade UM Moll 2003 Mutational analysis of p53 in human tumors: immunocytochemistry Methods Mol Biol 234 231 243 1:CAS:528:DC%2BD3sXls1Kgsrc%3D 12824536
20. YS Bian MC Osterheld FT Bosman, et al. 2001 p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus Mod Pathol 14 5 397 403 10.1038/modpathol.3880324 1:STN:280:DC%2BD3M3lsVyqtQ%3D%3D 11353048 (Pubitemid 32448736)
21. K Geboes P Van Eyken, et al. 2000 The diagnosis of dysplasia and malignancy in Barrett's oesophagus Histopathology 37 2 99 107 10.1046/j.1365-2559.2000.00960.x 1:STN:280:DC%2BD3cvisl2isA%3D%3D 10931231 (Pubitemid 30608506)
22. W Polkowski JJ van Lanschot FJ ten Kate, et al. 1995 The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence Surg Oncol 4 3 163 171 1:STN:280:DyaK28%2Fns1Gruw%3D%3D 7582189
23. L Herszenyi I Hritz I Pregun, et al. 2007 Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis World J Gastroenterol 13 5 676 682 1:CAS:528:DC%2BD2sXjtlajsL0%3D 17278189
24. I Hritz D Kuester M Vieth, et al. 2006 Secretory leukocyte protease inhibitor expression in various types of gastritis: a specific role of Helicobacter pylori infection Eur J Gastroenterol Hepatol 18 3 277 282 10.1097/00042737-200603000-00008 1:CAS:528:DC%2BD28XhtFeisLg%3D 16462541 (Pubitemid 43308192)
25. I Hritz L Herszenyi B Molnar, et al. 2005 Proton pump inhibitor co-therapy normalizes the increased cell turnover of the gastric mucosa both in NSAID and selective COX-2 users Int J Immunpathol Pharmacol 18 1 75 84 1:STN:280:DC%2BD2M%2FmvFaruw%3D%3D
26. I Hritz L Herszenyi B Molnar, et al. 2005 Long-term omeprazole and esomeprazole treatment does not significantly increase gastric epithelial cell proliferation and epithelial growth factor receptor expression and has no effect on apoptosis and p53 expression World J Gastroenterol 11 30 4721 4726 1:CAS:528:DC%2BD2MXhtVyiurnM 16094717
27. RC Fitzgerald, et al. 2006 Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma Gut 55 12 1810 1820 10.1136/gut.2005.089144 1:CAS:528:DC%2BD2sXkvFOisg%3D%3D 17124160 (Pubitemid 44893583)
28. BJ Reid WM Weinstein KJ Lewin, et al. 1988 Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions Gastroenterology 94 1 81 90 1:STN:280:DyaL1c%2FosVamtg%3D%3D 3335302
29. J Theisen JJ Nigro TR DeMeester, et al. 2004 Chronology of the Barrett's metaplasia-dysplasia-carcinoma sequence Dis Esophagus 17 1 67 70 10.1111/j.1442-2050.2004.00376.x 1:STN:280:DC%2BD2czgvVGhtQ%3D%3D 15209744 (Pubitemid 38807879)
30. J Kleeff H Friess Q Liao, et al. 2002 Immunohistochemical presentation in non-malignant and malignant Barrett's epithelium Dis Esophagus 15 1 10 15 10.1046/j.1442-2050.2002.00211.x 1:STN:280:DC%2BD38zhsleqtQ%3D%3D 12060037 (Pubitemid 34811993)
31. G Biasco, et al. 2004 Cell proliferation and differentiation in familial adenomatous polyposis (FAP) Hum Pathol 35 12 1573 10.1016/j.humpath.2004.08.006 15619221 (Pubitemid 40018001)
32. A Scalmati L Roncucci G Ghidini, et al. 1990 Epithelial cell kinetics in the remaining colorectal mucosa after surgery for cancer of the large bowel Cancer Res 50 24 7937 7941 1:STN:280:DyaK3M%2FntVGltg%3D%3D 2253235
33. P Bechi M Balzi A Becciolini, et al. 1996 Helicobacter pylori and cell proliferation of the gastric mucosa: possible implications for gastric carcinogenesis Am J Gastroenterol 91 2 271 276 1:STN:280:DyaK287ovF2rtw%3D%3D 8607492
34. FT Peters S Ganesh EJ Kuipers, et al. 1998 Epithelial cell proliferative activity of Barrett's esophagus: methodology and correlation with traditional cancer risk markers Dig Dis Sci 43 7 1501 1506 10.1023/A:1018858713965 1:STN:280:DyaK1czlt1KqtA%3D%3D 9690386 (Pubitemid 28357269)
35. N Rioux-Leclercq B Turlin F Sutherland, et al. 1999 Analysis of Ki-67, p53 and Bcl-2 expression in the dysplasia-carcinoma sequence of Barrett's esophagus Oncol Rep 6 4 877 882 1:STN:280:DyaK1MzgslKgtQ%3D%3D 10373674
36. R Kim MR Clarke MF Melhem, et al. 1997 Expression of p53, PCNA, and CerbB-2 in Barrett's metaplasia and adenocarcinoma Dig Dis Sci 42 12 2453 2462 10.1023/A:1018891923998 1:STN:280:DyaK1c7gtFGluw%3D%3D 9440619 (Pubitemid 28103779)
37. H Kataoka T Joh K Kasugai, et al. 1997 Mitogenic properties of human gastric juice Dig Dis Sci 42 8 1747 1754 10.1023/A:1018877918894 1:STN:280:DyaK2svjt1entw%3D%3D 9286244 (Pubitemid 27394601)
38. J Lagergren R Bergstrom A Lindgren, et al. 1999 Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma N Engl J Med 340 11 825 831 10.1056/NEJM199903183401101 1:STN:280:DyaK1M7msFeitw%3D%3D 10080844 (Pubitemid 29142625)
39. N Shaheen DF Ransohoff, et al. 2002 Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review JAMA 287 15 1972 1981 10.1001/jama.287.15.1972 11960540 (Pubitemid 34326418)
40. FT Peters S Ganesh EJ Kuipers, et al. 2000 Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus Scand J Gastroenterol 35 12 1238 1244 10.1080/003655200453557 1:CAS:528: DC%2BD3MXot1Gisg%3D%3D 11199360 (Pubitemid 32051635)
41. AP Ireland GW Clark TR DeMeester 1997 Barrett's esophagus. The significance of p53 in clinical practice Ann Surg 225 1 17 30 10.1097/00000658-199701000-00003 1:STN:280:DyaK2s7lt1Wrtw%3D%3D 8998117 (Pubitemid 27026800)
42. JF Flejou F Potet F Muzeau, et al. 1993 Overexpression of p53 protein in Barrett's syndrome with malignant transformation J Clin Pathol 46 4 330 333 10.1136/jcp.46.4.330 1:STN:280:DyaK3s3ms1ymsw%3D%3D 8496390
43. PM Schneider AG Casson B Levin, et al. 1996 Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of 98 cases J Thorac Cardiovasc Surg 111 2 323 331 10.1016/S0022-5223(96)70441-5 1:STN:280: DyaK287mtVyiuw%3D%3D 8583805 (Pubitemid 26054035)
44. JL Hornick M Mino-Kenudson GY Lauwers, et al. 2008 Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities Am J Gastroenterol 103 1 38 47 18076737
45. M Younes RM Lebovitz LV Lechago, et al. 1993 p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study Gastroenterology 105 6 1637 1642 1:CAS:528:DyaK2cXnsVCksw%3D%3D 8253340
46. WH Sun YL Sun RN Fang, et al. 2005 Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis Jpn J Clin Oncol 35 12 707 713 10.1093/jjco/hyi196 16314343 (Pubitemid 43091655)
47. T Takeuchi M Hisanaga M Nagao, et al. 2004 The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer Clin Cancer Res 10 16 5572 5579 10.1158/1078-0432.CCR-03-0656 1:CAS:528:DC%2BD2cXmvFSlurw%3D 15328199 (Pubitemid 39100498)
48. S Samantaray R Sharma TK Chattopadhyaya, et al. 2004 Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma J Cancer Res Clin Oncol 130 1 37 44 10.1007/s00432-003-0500-4 1:CAS:528:DC%2BD3sXps1yhtrk%3D 14569466 (Pubitemid 38161246)